XML 62 R40.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE CAPITAL (Tables)
 12 Months Ended
Mar. 31, 2025
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Disclosure of share purchase warrants outstandin [Table Text Block]
    Exercise     Grant Date     March 31,  
    Price     Fair Value     2025  
Expiry Date   $     $     #  
August 19, 2026   3.00     89,737     1,180,750  
Disclosure of summary of warrants activity [Table Text Block]
    Year ended
March 31, 2025		  
    Number     Weighted
average
 exercise price		  
          $  
Balance, beginning of year   -     -  
Granted   1,180,750     3.00  
Exercised   -     -  
Expired   -     -  
Balance, end of year   1,180,750     3.00  
Disclosure of detailed information about options, valuation assumptions [Table Text Block]
  Triera The Company
  Mar 31, 2025 Mar 31, 2024 Mar 31, 2025 Mar 31, 2024
Expected dividend yield 0% 0% 0% 0%
Expected volatility 98% to 120% 98% to 120% 62% to 77% 70% to 90%
Expected forfeiture rate 0% 0% 7% 5%
Risk-free interest rate 4.50% 3.90% 4.0% to 4.5% 3.6% to 4.5%
Expected life 3 years 3 to 5 years 3 to 5 years 3 to 5 years
Disclosure of share-based payment reserve [Table Text Block]
    Year     Year  
    Ended     Ended  
    March 31,     March 31,  
    2025     2024  
    $     $  
Share-based compensation expense   1,529,934     1,786,453  
Disclosure of stock option and share-based payment activity [Table Text Block]
    Year ended     Year ended  
    March 31, 2025     March 31, 2024  
          Weighted           Weighted  
          average           average  
    Number     exercise price     Number     exercise price  
          $           $  
                         
Balance, beginning of year   7,098,334     2.37     8,673,334     2.03  
Granted   2,000,000     1.52     1,250,000     2.03  
Exercised   (1,700,000 )   0.45     (2,000,000 )   0.54  
Expired   (1,275,000 )   3.84     (825,000 )   2.72  
Balance, end of year   6,123,334     2.32     7,098,334     2.37  
Disclosure of outstanding options to acquire common shares [Table Text Block]
    Options Outstanding     Options Exercisable  
          Weighted     Weighted           Weighted  
    Number     Average     Average     Number     Average  
    Outstanding     Remaining     Exercise     Outstanding     Exercise  
Range of exercise Prices   as at Mar 31,     Contractual     Price     as at Mar 31,     Price  
CAD$   2025     Life (years)     CAD$     2025     CAD$  
$0.40 - $1.00   633,334     0.28   $ 0.55     633,334   $ 0.55  
$1.01 - $4.00   4,465,000     2.75   $ 2.12     3,135,416   $ 2.37  
$4.01 - $5.67   1,025,000     1.79   $ 4.27     1,025,000   $ 4.27  
Totals   6,123,334     2.33   $ 2.32     4,793,750   $ 2.54  
    Options Outstanding     Options Exercisable  
          Weighted     Weighted           Weighted  
    Number     Average     Average     Number     Average  
    Outstanding     Remaining     Exercise     Outstanding     Exercise  
Range of exercise Prices   as at Mar 31,     Contractual     Price     as at Mar 31,     Price  
CAD$   2024     Life (years)     CAD$     2024     CAD$  
$0.40 - $1.00   2,333,334     0.79   $ 0.48     2,333,334   $ 0.48  
$1.01 - $4.00   3,025,000     2.52   $ 2.63     2,316,667   $ 2.81  
$4.01 - $5.67   1,740,000     2.04   $ 4.46     1,740,000   $ 4.46  
Totals   7,098,334     1.84   $ 2.37     6,390,001   $ 2.41  
Triera Biosciences Ltd [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Disclosure of stock option and share-based payment activity [Table Text Block]
    Year ended     Year ended  
    March 31, 2025     March 31, 2024  
          Weighted           Weighted  
          average           average  
    Number     exercise price     Number     exercise price  
          $           $  
Balance, beginning of year   195,000     1.00     -     -  
Granted   5,000     1.00     195,000     1.00  
Exercised   -     -     -     -  
Expired   (10,000 )   1.00     -     -  
Balance, end of year   190,000     1.00     195,000     1.00  
Disclosure of outstanding options to acquire common shares [Table Text Block]
    Options Outstanding     Options Exercisable  
          Weighted     Weighted           Weighted  
    Number     Average     Average     Number     Average  
    Outstanding     Remaining     Exercise     Outstanding     Exercise  
Range of exercise Prices   as at Mar 31,     Contractual     Price     as at Mar 31,     Price  
CAD$   2025     Life (years)     CAD$     2025     CAD$  
$0.00 - $1.00   200,000     3.22   $ 1.00     196,666   $ 1.00  
    Options Outstanding     Options Exercisable  
          Weighted     Weighted           Weighted  
    Number     Average     Average     Number     Average  
    Outstanding     Remaining     Exercise     Outstanding     Exercise  
Range of exercise Prices   as at Mar 31,     Contractual     Price     as at Mar 31,     Price  
CAD$   2024     Life (years)     CAD$     2024     CAD$  
$0.00 - $1.00   195,000     4.25   $ 1.00     65,000   $ 1.00